High-dose folic acid improves endothelial function by increasing tetrahydrobiopterin and decreasing homocysteine levels

Molecular Medicine Reports

Volumn 10, Issue 3, 2014, Pages 1609-1613

  Zhang, Min ^a   Wen, Jinlin ^a   Wang, Xiangjiang ^a   Xiao, Chun ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Folate; Homocysteine; Neopterin; Nitric oxide; Tetrahydrobiopterin

Indexed keywords

BIOPTERIN; FOLIC ACID; HOMOCYSTEINE; NEOPTERIN; NITRIC OXIDE; TETRAHYDROBIOPTERIN; SAPROPTERIN;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; UMBILICAL VEIN ENDOTHELIAL CELL; ANALOGS AND DERIVATIVES; CELL CULTURE; DOSE RESPONSE; DRUG EFFECTS; METABOLISM;

BIOPTERIN; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLIC ACID; HOMOCYSTEINE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NEOPTERIN; NITRIC OXIDE;

EID: 84905509099     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2332     Document Type: Article

References (22)

1. Hamon CG, Blair JA and Barford PA: The effect of tetrahydrofolate on tetrahydrobiopterin metabolism. J Ment Defic Res 30: 179-183, 1986. (Pubitemid 16089448)
2. Moens AL and Kass DA: Tetrahydrobiopterin and cardiovascular disease. Arterioscler Thromb Vasc Biol 26: 2439-2444, 2006. (Pubitemid 44607463)
3. Coppola A, Davi G, De Stefano V, et al: Homocysteine, coagulation, platelet function, and thrombosis. Semin Thromb Hemost 26: 243-254, 2000.
4. Bunout D, Garrido A, Suazo M, et al: Effects of supplementation with folic acid and antioxidant vitamins on homocysteine levels and LDL oxidation in coronary patients. Nutrition 16: 107-110, 2000. (Pubitemid 30103711)
5. Voutilainen S, Morrow JD, Roberts LJ II, et al: Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler Thromb Vasc Biol 19: 1263-1266, 1999. (Pubitemid 29227646)
6. Woo KS, Chook P, Lolin YI, et al: Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. J Am Coll Cardiol 34: 2002-2006, 1999. (Pubitemid 30002657)
7. Antoniades C, Shirodaria C, Warrick N, et al: 5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. Circulation 114: 1193-1201, 2006. (Pubitemid 44386484)
8. Alp NJ, Mussa S, Khoo J, et al: Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression. J Clin Invest 112: 725-735, 2003. (Pubitemid 38057713)
9. de Andrade CR, Leite PF, Montezano AC, et al: Increased endothelin-1 reactivity and endothelial dysfunction in carotid arteries from rats with hyperhomocysteinemia. Br J Pharmacol 157: 568-580, 2009.
10. Mahadeo KM, Dhall G, Panigrahy A, et al: Subacute methotrexate neurotoxicity and cerebral venous sinus thrombosis in a 12-year-old with acute lymphoblastic leukemia and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: homocysteine-mediated methotrexate neurotoxicity via direct endothelial injury. Pediatr Hematol Oncol 27: 46-52, 2010.
11. Papatheodorou L and Weiss N: Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid Redox Signal 9: 1941-1958, 2007. (Pubitemid 47628602)
12. Vizzardi E, Bonadei I, Zanini G, et al: Homocysteine and heart failure: an overview. Recent Pat Cardiovasc Drug Discov 4: 15-21, 2009.
13. Guilland JC, Favier A, Potier de Courcy G, et al: Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data. Pathol Biol (Paris) 51: 101-110, 2003 (In French). (Pubitemid 36427577)
14. Cattaneo M: Hyperhomocysteinemia and thrombosis. Lipids 36 (Suppl): S13-S26, 2001.
15. Herrmann W: The importance of hyperhomocysteinemia as a risk factor for diseases: an overview. Clin Chem Lab Med 39: 666-674, 2001.
16. Krebs HA, Hems R and Tyler B: The regulation of folate and methionine metabolism. Biochem J. 158: 341-353, 1976.
17. Zhang JG, Wang LZ, Han XQ, et al: The pathogenic mechanism of homocysteine -induced endothelial nitric oxide synthase dysfunction and the antagonistic effects by folic acid. Fen Zi Xi Bao Sheng Wu Xue Bao 40: 17-23, 2007 (In Chinese).
18. Aisaki K, Tsuboi I, Harada T, et al: Neopterin, inflammation-associated product, prolongs erythropoiesis suppression in aged SAMP1 mice due to senescent stromal-cell impairment. Exp Biol Med (Maywood) 237: 279-286, 2012.
19. Yadav AK, Sharma V and Jha V: Association between serum neopterin and inflammatory activation in chronic kidney disease. Mediators Inflamm 2012: 476979, 2012.
20. Zamani P, Ganz P, Libby P, et al: Relationship of antihypertensive treatment to plasma markers of vascular inflammation and remodeling in the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis study. Am Heart J 163: 735-740, 2012.
21. Hyndman ME, Verma S, Rosenfeld RJ, et al: Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function. Am J Physiol Heart Circ Physiol 282: H2167-H2172, 2002. (Pubitemid 34663027)
22. Ronco AM, Llanos M, Tamayo D and Hirsch S: 5-methyltetrahydrofolic acid stimulates endothelin-1 production in low density lipoprotein-treated human endothelial cells. Nutr Metab Cardiovasc Dis 17: 188-194, 2007. (Pubitemid 46400411)